⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNSE News

Sensei Biotherapeutics, Inc. Common Stock

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025